GROVER C DILS MEDICAL CENTER — History
CCN 291312 | 3-year financial timeline | COVID resilience: 46/100
🛡️ Public data only — no PHI permitted on this instance.
$7M
Latest Revenue (FY2022)
+4.3%
Revenue CAGR (3yr)
-27.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $6M | $6M | $7M | +11.4% | +4.3% |
| Operating Expenses | $8M | $8M | $9M | +13.7% | +6.8% |
| Operating Margin | -22.0% | -25.2% | -27.8% | -10.3% | +0.0% |
| Net Income | $-1M | $-2M | $-2M | -22.9% | +0.0% |
| Licensed Beds | 4 | 4 | 4 | +0.0% | +0.0% |
| Total Patient Days | 713 | 716 | 728 | +1.7% | +1.0% |
| Medicare Day % | 73% | 89% | 80% | -9.5% | +5.2% |
| Medicaid Day % | 8% | 4% | 7% | +74.8% | -10.7% |
COVID Impact & Recovery
Resilience Score: 46/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +8.9% ($6M → $7M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+4.3%
This Hospital
+7.6%
State Avg
Latest Margin
-27.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $7M | -30.6% |
| FY2024 (proj) | $7M | -33.5% |
| FY2025 (proj) | $8M | -36.3% |